SEARCH

SEARCH BY CITATION

References

  • Angelin-Duclos, C., Cattoretti, G., Lin, K.I. & Calame, K. (2000) Commitment of B lymphocytes to a plasma cell fate is associated with Blimp-1 expression in vivo. Journal of Immunology, 165, 54625471.
  • Angelin-Duclos, C., Johnson, K., Liao, J., Lin, K.I. & Calame, K. (2002) An interfering form of Blimp-1 increases IgM secreting plasma cells and blocks maturation of peripheral B cells. European Journal of Immunology, 32, 37653775.
  • Bataille, R., Robillard, N., Pellat Deceunynck, C. & Amiot, M. (2003) A cellular model for myeloma cell growth and maturation based on an intraclonal CD45 hierarchy. Immunological Review, 194, 105111.
  • Bernal, A., Pastore, R.D., Asgary, Z., Keller, S.A., Cesarman, E., Liou, H.C. & Schattner, E.J. (2001) Survival of leukemic B cells promoted by engagement of the antigen receptor. Blood, 98, 30503057.
  • Borson, N.D., Lacy, M.Q. & Wettstein, P.J. (2002) Altered mRNA expression of Pax5 and Blimp-1 in B cells in multiple myeloma. Blood, 100, 46294639.
  • Calame, K.L., Lin, K.I. & Tunyaplin, C. (2003) Regulatory mechanisms that determine the development and function of plasma cells. Annual Review of Immunology, 21, 205230.
  • Craxton, A., Chuang, P.I., Shu, G., Harlan, J.M. & Clark, E.A. (2000) The CD40-inducible Bcl-2 family member A1 protects B cells from antigen receptor-mediated apoptosis. Cellular Immunology, 200, 5662.
  • D'Sa-Eipper, C. & Chinnadurai, G. (1998) Functional dissection of Bfl-1, a Bcl-2 homolog: anti-apoptosis, oncogene-cooperation and cell proliferation activities. Oncogene, 16, 31053114.
  • Derenne, S., Monia, B., Dean, N.M., Taylor, J.K., Rapp, M.J., Harousseau, J.L., Bataille, R. & Amiot, M. (2002) Antisense strategy shows that Mcl-1 rather than Bcl-2 or Bcl-x(L) is an essential survival protein of human myeloma cells. Blood, 100, 194199.
  • Edelstein, L.C., Lagos, L., Simmons, M., Tirumalai, H. & Gelinas, C. (2003) NF-kappa B-dependent assembly of an enhanceosome-like complex on the promoter region of apoptosis inhibitor Bfl-1/A1. Molecular Cell Biology, 23, 27492761.
  • Eisen, M.B., Spellman, P.T., Brown, P.O. & Botstein, D. (1998) Cluster analysis and display of genome-wide expression patterns. Proceedings of the National Academy of Sciences of the United States of America, 95, 14 86314 868.
  • Feinman, R., Koury, J., Thames, M., Barlogie, B., Epstein, J. & Siegel, D.S. (1999) Role of NF-kappaB in the rescue of multiple myeloma cells from glucocorticoid-induced apoptosis by bcl-2. Blood, 93, 30443052.
  • Gonzalez, J., Orlofsky, A. & Prystowsky, M.B. (2003) A1 is a growth-permissive antiapoptotic factor mediating postactivation survival in T cells. Blood, 101, 26792685.
  • Grumont, R.J., Rourke, I.J. & Gerondakis, S. (1999) Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis. Genes and Development, 13, 400411.
  • Hideshima, T., Chauhan, D., Richardson, P., Mitsiades, C., Mitsiades, N., Hayashi, T., Munshi, N., Dang, L., Castro, A., Palombella, V., Adams, J. & Anderson, K.C. (2002) NF-kappa B as a therapeutic target in multiple myeloma. Journal of Biological Chemistry, 277, 16 63916 647.
  • Hinz, M., Loser, P., Mathas, S., Krappmann, D., Dorken, B. & Scheidereit, C. (2001) Constitutive NF-kappaB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells. Blood, 97, 27982807.
  • Hsu, S.Y., Kaipia, A., McGee, E., Lomeli, M. & Hsueh, A.J. (1997) Bok is a pro-apoptotic Bcl-2 protein with restricted expression in reproductive tissues and heterodimerizes with selective anti-apoptotic Bcl-2 family members. Proceedings of the National Academy of Sciences of the United States of America, 94, 12 40112 406.
  • Jourdan, M., De Vos, J., Mechti, N. & Klein, B. (2000) Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1. Cell Death and Differentiation, 7, 12441252.
  • Jourdan, M., Veyrune, J.L., Vos, J.D., Redal, N., Couderc, G. & Klein, B. (2003) A major role for Mcl-1 antiapoptotic protein in the IL-6-induced survival of human myeloma cells. Oncogene, 22, 29502959.
  • Karsan, A., Yee, E. & Harlan, J.M. (1996) Endothelial cell death induced by tumor necrosis factor-α is inhibited by the Bcl-2 family member, A1. Journal of Biological Chemistry, 271, 2720127204.
  • Knödel, M., Kuss, A.W., Lindemann, D., Berberich, I. & Schimpl, A. (1999) Reversal of Blimp-1-mediated apoptosis by A1, a member of the Bcl-2 family. European Journal of Immunology, 29, 29882998.
  • Kuss, A.W., Knodel, M., Berberich-Siebelt, F., Lindemann, D., Schimpl, A. & Berberich, I. (1999) A1 expression is stimulated by CD40 in B cells and rescues WEHI 231 cells from anti-IgM-induced cell death. European Journal of Immunology, 29, 30773088.
  • Lee, H.H., Dadgostar, H., Cheng, Q., Shu, J. & Cheng, G. (1999) NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes. Proceedings of the National Academy of Sciences of the United States of America, 96, 91369141.
  • Lin, E.Y., Orlofsky, A., Berger, M.S. & Prystowsky, M.B. (1993) Characterization of A1, a novel hemopoietic-specific early response gene with sequence similarity to bcl-2. Journal of Immunology, 151, 19791988.
  • Lin, K.I., Lin, Y. & Calame, K. (2000) Repression of c-myc is necessary but not sufficient for terminal differentiation of B lymphocytes in vitro. Molecular Cell Biology, 20, 86848695.
  • Lin, K.I., Angelin-Duclos, C., Kuo, T.C. & Calame, K. (2002) Blimp-1-dependent repression of pax-5 is required for differentiation of B cells to immunoglobulin m-secreting plasma cells. Molecular Cell Biology, 22, 47714780.
  • Manz, R.A., Arce, S., Cassese, G., Hauser, A.E., Hiepe, F. & Radbruch, A. (2002) Humoral immunity and long-lived plasma cells. Current Opinion of Immunology, 14, 517521.
  • Medina, F., Segundo, C., Campos-Caro, A., Gonzalez-Garcia, I. & Brieva, J.A. (2002) The heterogeneity shown by human plasma cells from tonsil, blood, and bone marrow reveals graded stages of increasing maturity, but local profiles of adhesion molecule expression. Blood, 99, 21542161.
  • Medina, F., Segundo, C., Campos-Caro, A., Salcedo, I., Garcia-Poley, A. & Brieva, J.A. (2003) Isolation, maturational level, and functional capacity of human colon lamina propria plasma cells. Gut, 52, 383389.
  • Mitsiades, C.S., Mitsiades, N., Poulaki, V., Schlossman, R., Akiyama, M., Chauhan, D., Hideshima, T., Treon, S.P., Munshi, N.C., Richardson, P.G. & Anderson, K.C. (2002a) Activation of NF-kappaB and upregulation of intracellular anti- apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications. Oncogene, 21, 56735683.
  • Mitsiades, N., Mitsiades, C.S., Poulaki, V., Chauhan, D., Richardson, P.G., Hideshima, T., Munshi, N., Treon, S.P. & Anderson, K.C. (2002b) Biologic sequelae of nuclear factor-kappaB blockade in multiple myeloma: therapeutic applications. Blood, 99, 40794086.
  • Moreaux, J., Legouffe, E., Jourdan, E., Quittet, P., Reme, T., Lugagne, C., Moine, P., Rossi, J.F., Klein, B. & Tarte, K. (2004) BAFF and APRIL protect myeloma cells from apoptosis induced by IL-6 deprivation and dexamethasone. Blood, in press.
  • Moreb, J.S. & Zucali, J. (2001) Human A1 expression in acute myeloid leukemia and its relationship to Bcl-2 expression. Blood, 97, 578579.
  • Moulding, D.A., Akgul, C., Derouet, M., White, M.R. & Edwards, S.W. (2001) BCL-2 family expression in human neutrophils during delayed and accelerated apoptosis. Journal of Leukocyte Biology, 70, 783792.
  • Nieborowska-Skorska, M., Hoser, G., Kossev, P., Wasik, M.A. & Skorski, T. (2002) Complementary functions of the antiapoptotic protein A1 and serine/threonine kinase pim-1 in the BCR/ABL-mediated leukemogenesis. Blood, 99, 45314539.
  • Pham, L.V., Tamayo, A.T., Yoshimura, L.C., Lo, P. & Ford, R.J. (2003) Inhibition of constitutive NF-kB activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis. Journal of Immunology, 171, 8895.
  • Piskurich, J.F., Lin, K., Lin, Y., Wang, Y., Ting, J.P.Y. & Calame, K. (2000) BLIMP-I mediates extinction of major histocompatibility class II transactivator expression in plasma cells. Nature Immunology, 1, 526532.
  • Richardson, P.G., Barlogie, B., Berenson, J., Singhal, S., Jagannath, S., Irwin, D., Rajkumar, S.V., Srkalovic, G., Alsina, M., Alexanian, R., Siegel, D., Orlowski, R.Z., Kuter, D., Limentani, S.A., Lee, S., Hideshima, T., Esseltine, D.-L., Kauffman, M., Adams, J., Schenkein, D.P. & Anderson, K.C. (2003) A phase 2 study of Bortezomib in relapsed, refractory myeloma. New England Journal of Medicine, 348, 26092617.
  • Schliephake, D.E. & Schimpl, A. (1996) Blimp-1 overcomes the block in IgM secretion in lipopolysaccharide/anti-mu F(ab′)2-co-stimulated B lymphocytes. European Journal of Immunology, 26, 268271.
  • Shaffer, A.L., Lin, K.I., Kuo, T.C., Yu, X., Hurt, E.M., Rosenwald, A., Giltnane, J.M., Yang, L., Zhao, H., Calame, K. & Staudt, L.M. (2002) Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity, 17, 5162.
  • Shapiro-Shelef, M., Lin, K.I., McHeyzer-Williams, L.J., Liao, J., McHeyzer-Williams, M.G. & Calame, K. (2003) Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells. Immunity, 19, 607620.
  • Slifka, M.K., Antia, R., Whitmire, J.K. & Ahmed, R. (1998) Humoral immunity due to long-lived plasma cells. Immunity, 8, 363372.
  • Tarte, K., de Vos, J., Thykjaer, T., Zhan, F., Fiol, G., Costes, V., Rème, T., Legouffe, E., Rossi, J.F., Shaughnessy, J., Orntoft, T.F. & Klein, B. (2002) Generation of polyclonal plasmablasts from peripheral blood B cells: a normal counterpart of malignant plasmablasts. Blood, 100, 11131122.
  • Tarte, K., Zhan, F., De Vos, J., Klein, B. & Shaughnessy, J. (2003) Gene expression profiling of plasma cells and plasmablasts: toward a better understanding of the late stages of B-cell differentiation. Blood, 102, 592600.
  • Tomayko, M.M. & Cancro, M.P. (1998) Long-lived B cells are distinguished by elevated expression of A1. Journal of Immunology, 160, 107111.
  • Wen, R., Chen, Y., Xue, L., Schuman, J., Yang, S., Morris, S.W. & Wang, D. (2003) Phospholipase Cgamma2 provides survival signals via Bcl2 and A1 in different subpopulations of B cells. Journal of Biological Chemistry, 278, 43 65443 662.
  • Werner, A.B., de Vries, E., Tait, S.W., Bontjer, I. & Borst, J. (2002) Bcl-2 family member Bfl-1/A1 sequesters truncated bid to inhibit is collaboration with pro-apoptotic Bak or Bax. Journal of Biological Chemistry, 277, 22 78122 788.
  • Zhan, F., Hardin, J., Bumm, K., Zheng, M., Tian, E., Sanderson, R.D., Yang, Y., Wilson, C., Zangari, M., Anaissie, E., Morris, C., Muwalla, F., van Rhee, F., Fassas, A., Crowley, J., Tricot, G., Barlogie, B. & Shaughnessy, J. (2002) Molecular profiling of multiple myeloma. Blood, 99, 17451757.
  • Zhan, F., Tian, E., Bumm, K., Smith, R., Barlogie, B. & Shaughnessy, J. (2003) Profiling of human plasma cell differentiation and classification of multiple myeloma based on similarities to distinct stages of late-stage B-cell development. Blood, 101, 11281140.
  • Zhang, X.G., Gaillard, J.P., Robillard, N., Lu, Z.Y., Gu, Z.J., Jourdan, M., Boiron, J.M., Bataille, R. & Klein, B. (1994) Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma. Blood, 83, 36543663.
  • Zong, W.X., Edelstein, L.C., Chen, C., Bash, J. & Gelinas, C. (1999) The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis. Genes and Development, 13, 382387.